| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 7 |
| 1 | INSULIN GLARGINE | 3 |
| 2 | INSULIN GLARGINE-YFGN | 3 |
| 3 | METFORMIN | 3 |
| 4 | METFORMIN ER 500 MG | 2 |
| 5 | METFORMIN ER 750 MG | 2 |
| 6 | PITAVASTATIN | 2 |
| 7 | PITAVASTATIN CALCIUM | 2 |
| 8 | ADALIMUMAB | 1 |
| 9 | ADALIMUMAB-AATY | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PITAVASTATIN CALCIUM | 2 | 0.0002 |
| 1 | INSULIN GLARGINE-YFGN | 3 | 0.0001 |
| 2 | EVOLOCUMAB | 7 | 0.0000 |
| 3 | TICAGRELOR | 1 | 0.0000 |
| 4 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 5 | ADALIMUMAB-AATY | 1 | 0.0000 |
| 6 | ADALIMUMAB-ADAZ | 1 | 0.0000 |
| 7 | METFORMIN HYDROCHLORIDE TABLETS | 1 | 0.0000 |
| 8 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 1 | 0.0000 |
| 9 | METFORMIN HYDROCHLORIDE TABLET | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 2 | P2Y12 Platelet Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Insulin Analog [EPC] | 3 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |